Legal Representation
Attorney
Sharon R. Smith
USPTO Deadlines
Next Deadline
59 days remaining
Statement of Use Due - Extension 5 Granted
Due Date
September 13, 2025
Application History
37 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 17, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jun 17, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Jun 16, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Feb 25, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Feb 24, 2025 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Aug 18, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Aug 18, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Aug 18, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Feb 8, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Feb 6, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Feb 6, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Feb 6, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Aug 10, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Aug 8, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Aug 8, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Aug 8, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Mar 9, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Mar 7, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Mar 7, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Mar 7, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Feb 15, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Feb 15, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Feb 15, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Sep 13, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Jul 19, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jul 19, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jun 29, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jun 16, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jun 10, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jun 10, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jun 10, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Dec 13, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Dec 13, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Dec 13, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Dec 13, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jul 28, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Apr 23, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceuticals for the treatment, diagnosis or prophylaxis of human diseases, disorders and conditions, namely, cancer, and diseases, disorders and conditions of the hematological systems
Classification
International Classes
005